DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of “Hold” from Analysts

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been assigned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $28.40.

A number of brokerages have recently weighed in on XRAY. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho began coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price target for the company. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, UBS Group cut their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a report on Tuesday, December 3rd.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. UMB Bank n.a. increased its position in DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA in the 3rd quarter valued at approximately $27,000. LRI Investments LLC increased its position in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the period. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA in the 3rd quarter valued at approximately $35,000. Finally, Rothschild Investment LLC acquired a new position in DENTSPLY SIRONA in the 2nd quarter valued at approximately $32,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $19.72 on Monday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a market capitalization of $3.92 billion, a P/E ratio of -9.53, a P/E/G ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a 12-month low of $17.21 and a 12-month high of $37.60. The firm has a 50-day moving average price of $21.28 and a two-hundred day moving average price of $24.16.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.49 EPS. Analysts anticipate that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.25%. DENTSPLY SIRONA’s payout ratio is -30.92%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.